Spots Global Cancer Trial Database for Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Official Title: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Study ID: NCT01199978

Conditions

Vestibular Schwannoma

Acoustic Neuroma

Interventions

Fractionated proton radiation

Losartan

Study Description

Brief Summary: In this research study we are looking at another type of radiation called proton radiation which is known to spare surrounding normal tissues from radiation. The proton radiation will be delivered using fractionated stereotactic radiotherapy (FSRT) to improve localization of the small tumor target. Proton radiation delivers minimal radiation beyond the area of the tumor. This may reduce side effects that patients would normally experience with conventional radiation therapy. In this research study, we are looking to determine the effects of fractionated proton radiotherapy on long-term hearing preservation and controlling tumor growth.

Detailed Description: * Proton radiation will be delivered daily for approximately 5.5 weeks. Participants will be assessed weekly for any side effects they may be experiencing. * Participants will have a follow-up visit 6 months after their last proton radiation treatment and then every year from the time of treatment completion for 5 years. The following tests and procedures will be performed at these visits: medical history, physical exam, MRI scan, comprehensive hearing tests and a questionnaire.